Imaging of lung cancer with fluorine-18 fluorodeoxyglucose:: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system

被引:52
|
作者
Weber, WA
Neverve, J
Sklarek, J
Ziegler, SI
Bartenstein, P
King, B
Treumann, T
Enterrottacher, A
Krapf, M
Häussinger, KE
Lichte, H
Präuer, HW
Thetter, O
Schwaiger, M
机构
[1] Tech Univ Munich, Dept Nucl Med, D-8000 Munich, Germany
[2] Tech Univ Munich, Dept Surg, D-8000 Munich, Germany
[3] Tech Univ Munich, Dept Radiol, D-8000 Munich, Germany
[4] Fachklin Munchen, Dept Surg, Gauting, Germany
[5] Fachklin Munchen, Dept Radiol, Gauting, Germany
[6] Fachklin Munchen, Dept Internal Med, Gauting, Germany
[7] Fachklin Munchen, Dept Nucl Med, Gauting, Germany
关键词
positron emission tomography; dual-detector coincidence imaging fluorodeoxyglucose; lung cancer;
D O I
10.1007/s002590050402
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Dual-head gamma cameras operated in coincidence mode are a new approach for tumour imagine using fluorine-18 fluorodeoxyglucose (FDG). The aim of this study was to assess the diagnostic accuracy of such a camera system in comparison with a full-ring positron emission tomography (PET) system in patients with lung cancer. Twenty-seven patients (1 female, 26 males, age 62+/-9 years) with lung cancer or indeterminate pulmonary nodules were studied on the same day with a full-ring PET scanner (Siemens ECAT EXACT) and a coincidence gamma camera system (ADAC Vertex MCD). Sixty minutes after injection of 185-370 MBq FDG, a scan of the chest was performed with the full-ring. system, Approximately 2 h p.i.. the coincidence camera study was performed. Coincidence gamma camera (CGC and PET images with (PETac) and without attenuation correction (PETnac) were analysed independently by two blinded observers. In addition. FDG uptake in primary rumours and involved lymph nodes was quantified relative to normal contralateral lung (T/L ratios). All primary rumours were histologically proven. The lymph node status was histologically determined in 23 patients. In four patients, no lymph node sampling was performed because of extensive disease or concurrent illnesses. In the 27 patients, 25 primary lung cancers and two metastatic lesions were histologically diagnosed. The number of coincidences per centimetre axial field of view was 3.33+/-0.93x10(5) for the CGC and 1.09+/-0.36x10(6) for the dedicated PET system, All primary rumours (size: 4,6+/-2,6 cm) were correctly identified in the CGC and dedicated PET studies. T/L ratios were 4.7+/-2.5 for CGC and 6.9+/-2.8 for PETnac (P<0.001). Histopathological evaluation revealed lymph node metastases in 11 of 88 sampled lymph node stations (size, 2.3+/-1.0 cm), All lymph node metastases were identified in the PETac studies, while PETnac detected 10/11 and CGC 8/11, For positive lymph nodes that were visible in CGC and PETnac studies, T/L ratios were 3.7+/-2.3 for CGC and 6.6+/-3.1 for PETnac (P=0.02). The diameters of false negative lymph nodes in the CGC studies were 0.75, 1.5 and 2 cm. False-positive FDG uptake in lymph nodes was found in two patients with all three imaging methods. For all lesions combined, T/L ratios in CGC relative to PETnac studies decreased significantly with decreasing lesion size (r=0.62; P<0.001), In conclusion, compared with a full-ring PET system the sensitivity of CGC imaging for detection of lung cancer is limited by a lower image contrast which deteriorates with decreasing lesion size. Nevertheless, the ability of CGC imaging to detect pulmonary lesions with a diameter of at least 2 cm appears to be similar to that of a full-ring system. Both systems provide a similar specificity fur the evaluation of lymph node involvement.
引用
收藏
页码:388 / 395
页数:8
相关论文
共 50 条
  • [41] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    Boerner, AR
    Weckesser, M
    Herzog, H
    Schmitz, T
    Audretsch, W
    Nitz, U
    Bender, HG
    Mueller-Gaertner, HW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) : 226 - 230
  • [42] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer:: results of a multicentre study
    Grünwald, F
    Kälicke, T
    Feine, U
    Lietzenmayer, R
    Scheidhauer, K
    Dietlein, M
    Schober, O
    Lerch, H
    Brandt-Mainz, K
    Burchert, W
    Hiltermann, G
    Cremerius, U
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (12) : 1547 - 1552
  • [43] CLINICAL SIGNIFICANCE OF FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR RECURRENT COLORECTAL CANCER
    Ishikawa, H.
    Watanabe, A.
    Ohyama, T.
    Mukogawa, T.
    Inoue, T.
    Kinoshita, S.
    Kawai, N.
    Nakagawa, K.
    Emoto, K.
    Ogawa, S.
    GUT, 2009, 58 : A86 - A86
  • [44] The influence of fluorine-18 fluorodeoxyglucose positron emission tomography (PET) on the clinical management of patients with head and neck cancer
    McCammon, R.
    Furuya, C.
    Raben, D.
    Song, J.
    Kane, M.
    Gaspar, L.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S184 - S185
  • [45] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study
    Frank Grünwald
    Thomas Kälicke
    Ulrich Feine
    Roland Lietzenmayer
    Klemens Scheidhauer
    Markus Dietlein
    Otmar Schober
    Hartmut Lerch
    Katja Brandt-Mainz
    Wolfgang Burchert
    Gerhard Hiltermann
    Uwe Cremerius
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine, 1999, 26 : 1547 - 1552
  • [46] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    Boerner, A.R.
    Weckesser, M.
    Herzog, H.
    Schmitz, T.
    Audretsch, W.
    Nitz, U.
    Bender, H.G.
    Mueller-Gaertner, H.-W.
    European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (03): : 226 - 230
  • [47] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
    Grünwald, Frank
    Kälicke, Thomas
    Feine, Ulrich
    Lietzenmayer, Roland
    Scheidhauer, Klemens
    Dietlein, Markus
    Schober, Otmar
    Lerch, Hartmut
    Brandt-Mainz, Katja
    Burchert, Wolfgang
    Hiltermann, Gerhard
    Cremerius, Uwe
    Biersack, Hans-Jürgen
    European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (12): : 1547 - 1552
  • [48] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    A. R. Boerner
    M. Weckesser
    H. Herzog
    T. Schmitz
    W. Audretsch
    U. Nitz
    H. G. Bender
    H.-W. Mueller-Gaertner
    European Journal of Nuclear Medicine, 1999, 26 : 226 - 230
  • [49] The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomography
    Stokkel, MPM
    Terhaard, CHJ
    Hordijk, GJ
    van Rijk, PP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) : 767 - 773
  • [50] The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomography
    Marcel P. M. Stokkel
    Chris H. J. Terhaard
    Gerrit-Jan Hordijk
    Peter P. van Rijk
    European Journal of Nuclear Medicine, 1999, 26 : 767 - 773